American Journal Of Pathology · 2011 · 123 citations · 25 references
Life SciencesNeurologyNeuroscienceDementiaNeurodegenerationNeuroimmunologyCerebrospinal Fluid BiomarkersComplement SystemMultiple System AtrophyNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseC3 Complement LevelsCerebrospinal Fluid DiagnosisCerebrospinal Fluid Inflammatory BiomarkersCerebrospinal Fluid Neurodegeneration MarkersComplement In Neurodegenerative DiseaseComplement In NeuroinflammationParkinson Disease Neuroimmunology
25
The Clinical Dementia Rating (CDR)
John C. Morris · Neurology · 1993 · 10K citations
Medicine, Neurology, Psychiatry +12
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman, Gregor K. Wenning, Phillip A. Low et al. · Neurology · 2008 · 3.2K citations · Full text
Consensus statement on the diagnosis of multiple system atrophy
Niall Quinn, Alberto Albanese, Yoav Ben‐Shlomo et al. · Journal of the Neurological Sciences · 1999 · 918 citations
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
Zhen Hong, Min Shi, Kathryn A. Chung et al. · Brain · 2010 · 608 citations · Full text
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
Min Shi, Joshua M. Bradner, Aneeka M. Hancock et al. · Annals of Neurology · 2010 · 420 citations